X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215724
https://recalls-rappels.canada.ca/en/alert-recall/apo-acyclovir-tablets-ndma-impurity
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215669
https://www.newswire.ca/news-releases/advisory-apotex-recalls-apo-acyclovir-tablets-due-to-a-nitrosamine-impurity-831622325.html
https://recalls-rappels.canada.ca/en/alert-recall/apo-acyclovir-tablets-ndma-impurity
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212202
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-12-2021-1620796745.pdf
https://www.prnewswire.com/news-releases/preparation-products-of-yiling-pharma-approved-by-fda-for-launch-in-the-us-market-301134272.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212252
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212718
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212718
https://www.fiercepharma.com/manufacturing/india-hoping-to-challenge-chinese-dominance-plans-drug-ingredient-production-push
https://www.pharmacompass.com/pdf/news/health-canada-issues-recalls-of-bausch-health-canadas-1587214692.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212495
https://www.fiercepharma.com/manufacturing/coronavirus-spurs-india-to-restrict-exports-two-dozen-drugs
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201501
https://www.in-pharmatechnologist.com/Article/2019/08/19/UIC-researchers-see-increased-efficacy-in-herpes-drug-with-addition-of-activated-carbon
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2019-1557900358.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205659
https://www.biospectrumasia.com/news/34/12750/perrigo-to-launch-its-ab-rated-generic-zovirax-cream.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208702
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209971
https://www.pharmacompass.com/pdf/news/myrxaffiliate-program-receives-fda-warning-letter-1549432716.pdf
https://www.pharmacompass.com/pdf/news/terapharm-receives-fda-warning-letter-1549432959.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209000
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-usfda-nod-for-acyclovir-ointment/articleshow/63678338.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-7-2018-1520410330.pdf
https://www.pharmacompass.com/pdf/news/apace-packaging-issues-voluntary-nationwide-recall-of-acyclovir-lot-19900-1518589059.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205591
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206261
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-21-2017-1498020666.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-14-2017-1497417449.pdf
http://www.prnewswire.com/news-releases/slayback-pharma-announces-the-final-approval-and-launch-of-generic-zovirax-acyclovir-ointment-5-300383519.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205469
https://www.pharmacompass.com/pdf/news/agency-starts-test-1800-product-samples-1478694153.pdf
https://www.pharmacompass.com/pdf/news/fougera-pharms-incs-generic-acyclovir-approved-in-us-as-an-antiviral-medication-1463220400.pdf
http://www.pharma-excipients.ch/2016/04/01/improving-oral-bioavailability-of-acyclovir-using-nanoparticulates-of-thiolated-xyloglucan/
http://www.pharma-excipients.ch/2016/03/31/reply-to-on-the-effect-of-common-excipients-on-the-oral-absorption-of-class-3-drugs/
http://www.pharma-excipients.ch/2016/03/31/effect-of-common-excipients-on-the-oral-drug-absorption-of-biopharmaceutics-classification-system-class-3-drugs-cimetidineand-acyclovir/
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cadila-gets-usfda-nod-to-sell-generic-anti-viral-drug/articleshow/51598189.cms
https://www.pharmacompass.com/pdf/news/zydus-pharms-usas-generic-acyclovir-approved-in-us-as-an-antiviral-drug-1459335531.pdf
http://www.pharma-excipients.ch/2016/02/29/piperine-containing-floating-microspheres-an-approach-for-drug-targeting-to-the-upper-gastrointestinal-tract/
http://www.in-pharmatechnologist.com/Ingredients/US-Gov-rules-CDMO-s-Acyclovir-not-made-in-US-due-to-Asian-API
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/suspensos+lotes+de+medicamentos+da+empresa+prati+donaduzzi
http://www.financialexpress.com/article/lifestyle/health/anti-herpes-drug-may-help-treat-hiv-study/53873/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0361-2015&w=01282015&lang=eng
Market Place
Share 
